Ignyte Acquisition Corp Performance

PKBODelisted Stock  USD 1.31  0.09  6.43%   
The company retains a Market Volatility (i.e., Beta) of 1.35, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ignyte Acquisition will likely underperform. Ignyte Acquisition Corp right now retains a risk of 0.0%. Please check out Ignyte Acquisition skewness, as well as the relationship between the day median price and relative strength index , to decide if Ignyte Acquisition will be following its current trending patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ignyte Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Ignyte Acquisition is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Total Cashflows From Investing Activities-9880.00
  

Ignyte Acquisition Relative Risk vs. Return Landscape

If you would invest  131.00  in Ignyte Acquisition Corp on August 26, 2024 and sell it today you would earn a total of  0.00  from holding Ignyte Acquisition Corp or generate 0.0% return on investment over 90 days. Ignyte Acquisition Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Ignyte, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Ignyte Acquisition Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Ignyte Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ignyte Acquisition Corp, and traders can use it to determine the average amount a Ignyte Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PKBO
Based on monthly moving average Ignyte Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ignyte Acquisition by adding Ignyte Acquisition to a well-diversified portfolio.

Ignyte Acquisition Fundamentals Growth

Ignyte Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ignyte Acquisition, and Ignyte Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ignyte Pink Sheet performance.

About Ignyte Acquisition Performance

By examining Ignyte Acquisition's fundamental ratios, stakeholders can obtain critical insights into Ignyte Acquisition's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Ignyte Acquisition is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency . Peak Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.

Things to note about Ignyte Acquisition Corp performance evaluation

Checking the ongoing alerts about Ignyte Acquisition for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ignyte Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ignyte Acquisition is not yet fully synchronised with the market data
Ignyte Acquisition may become a speculative penny stock
Ignyte Acquisition has a very high chance of going through financial distress in the upcoming years
Ignyte Acquisition Corp currently holds 6.22 M in liabilities. Ignyte Acquisition Corp has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Ignyte Acquisition until it has trouble settling it off, either with new capital or with free cash flow. So, Ignyte Acquisition's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ignyte Acquisition Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ignyte to invest in growth at high rates of return. When we think about Ignyte Acquisition's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 377.14 K. Net Loss for the year was (8.29 M) with loss before overhead, payroll, taxes, and interest of (6.6 M).
Ignyte Acquisition Corp currently holds about 147.56 K in cash with (8.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 34.0% of the company outstanding shares are owned by corporate insiders
Evaluating Ignyte Acquisition's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ignyte Acquisition's pink sheet performance include:
  • Analyzing Ignyte Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ignyte Acquisition's stock is overvalued or undervalued compared to its peers.
  • Examining Ignyte Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ignyte Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ignyte Acquisition's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ignyte Acquisition's pink sheet. These opinions can provide insight into Ignyte Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ignyte Acquisition's pink sheet performance is not an exact science, and many factors can impact Ignyte Acquisition's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Ignyte Pink Sheet

If you are still planning to invest in Ignyte Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ignyte Acquisition's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk